Successful restart of production as scheduled

LION confirms successful NMC+ production restart at end of June, reducing execution risk; FY26e revenue of €36.4m (+28.5% yoy) and positive EBITDA on track to meet the FY26 guidance. Maintaining BUY at PT €3.20.